MARIETTA, Ga., Dec. 16, 2015 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and
All News
CareFusion announced the FDA 510(k) clearances for its 13-gauge AVAmax vertebral balloon system and its 11-gauge AVAmax vertebral balloon system. The new 13-gauge system has a balloon that fits down a 13-gauge cannula, which has a cross-sectional area …
LAKE FOREST, Calif., Dec. 17, 2015 /PRNewswire/ — A 3-year prospective medical study conducted in collaboration between Singapore General Hospital and the Mayo Clinic, between June 2011 and November 2014 has concluded that treatment with Tenex Health’s TX System provides sustained pain relief and functional improvement for
HUNTLEY, Ill.–(BUSINESS WIRE)–Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that the U.S. Food and Drug Administration (FDA) has given 510(k) marketing clearance to the GRUVE
No increased adverse events seen for surgically treated unreduced vs reduced distal radius fractures
By Casey Tingle Patients with distal radius fractures that were splinted without reduction prior to open reduction and internal fixation did not have increased adverse events or subsequent surgeries compared with patients who underwent manipulative red…
No benefit in function seen with minimally invasive plate osteosynthesis for humeral shaft fractures
By Monica Jaramillo Compared with open reduction and internal fixation, minimally invasive plating osteosynthesis was linked with a higher rate of postoperative malrotation of greater than 20° and did not improve function or restore strength in patients with humeral shaft
InVivo Therapeutics announced the FDA has given the company conditional approval to convert an ongoing study into the pivotal probable benefit study called, “ The INSPIRE Study: InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold for Safety and Neurological
LONDON, UK (GlobalData), 17 December 2015 – The global market for spinal non-fusion treatments will expand from just under $521 million in 2014 to $749 million by 2021, at a Compound Annual Growth Rate (CAGR) of 5.3%, according to research
CAESAREA, Israel–(BUSINESS WIRE)– Mazor Robotics Ltd. (TASE:MZOR)(NASDAQGM:MZOR), a developer of innovative guidance systems and complementary products, announced today that it received the 100th order for the Renaissance system. The 100th system was purchased by UConn Health, located in Farmington, CT and
© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1